Acute coronary syndrome: What is the cost-effectiveness of prevention, point-of-care technology and telemonitoring?

被引:6
|
作者
Van Dyck, Walter [1 ]
Vertes, Gergely [1 ]
Palaniappan, Muhilan [1 ]
Gassull, Daniel [1 ]
Jain, Prateek [1 ]
Schulthess, Duane [2 ]
Tambuyzer, Erik [2 ]
Hudson, Richard [2 ]
Moran, Nuala [2 ]
机构
[1] Vlerick Leuven Gent Management Sch, B-9000 Ghent, Belgium
[2] Sci Business, B-1040 Brussels, Belgium
关键词
D O I
10.1016/j.hlpt.2012.07.002
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
This study is a cost-analysis that calculates the impact of three interventions for patients identified as 'at risk' for Acute Coronary Syndrome - a cardio-vascular exercise programme, point-of-care digital diagnostics, and telemonitoring adherence tools. The methodology utilizes a model of the annualized costs of ACS for the entire treatment value chain, and measures the impact of the three interventions by the change in treatment cost, incremental net benefit, and QALY. The results demonstrate that the largest impact is measured when all three interventions are utilized simultaneously producing a cumulative savings of 4424 and 0.126 QALY per patient. We also find a significant decrease in Emergency Room visits by 15% and changes in rates of utilization of Catharization (-59%), Angioplasty (-59%), Bypass (-17%), Medication (-14%) and Rehabilitation (-13%). (C) 2012 Fellowship of Postgraduate Medicine. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:173 / 177
页数:5
相关论文
共 50 条
  • [31] Cost-effectiveness of point-of-care testing for influenza at community pharmacy setting in Hong Kong
    Tam, Lok-pui
    You, Joyce
    PHARMACOTHERAPY, 2016, 36 (12): : E263 - E263
  • [32] Cost-effectiveness Analysis of Rivaroxaban in the Secondary Prevention of Acute Coronary Syndromes in Sweden
    Begum N.
    Stephens S.
    Schoeman O.
    Fraschke A.
    Kirsch B.
    Briere J.-B.
    Verheugt F.W.A.
    van Hout B.A.
    Cardiology and Therapy, 2015, 4 (2) : 131 - 153
  • [33] COST-EFFECTIVENESS ANALYSIS OF RIVAROXABAN IN THE SECONDARY PREVENTION OF ACUTE CORONARY SYNDROMES IN GREECE
    Stafylas, P.
    Karaiskou, M.
    Arzoumanidou, D.
    Kolevris, N.
    Kotsanis, A.
    Chatzopoulos, S.
    Stephens, S.
    Schoeman, O.
    Briere, J.
    Kanakakis, I
    VALUE IN HEALTH, 2018, 21 : S105 - S105
  • [34] Cost-effectiveness of ticagrelor versus clopidogrel for the prevention of atherothrombotic events in adult patients with acute coronary syndrome in Germany
    Theidel, Ulrike
    Asseburg, Christian
    Giannitsis, Evangelos
    Katus, Hugo
    CLINICAL RESEARCH IN CARDIOLOGY, 2013, 102 (06) : 447 - 458
  • [35] Cost-effectiveness of ticagrelor versus clopidogrel for the prevention of atherothrombotic events in adult patients with acute coronary syndrome in Germany
    Ulrike Theidel
    Christian Asseburg
    Evangelos Giannitsis
    Hugo Katus
    Clinical Research in Cardiology, 2013, 102 : 447 - 458
  • [36] Point-of-care HIV viral load in pregnant women without prenatal care: a cost-effectiveness analysis
    Avram, Carmen M.
    Greiner, Karen S.
    Tilden, Ellen
    Caughey, Aaron B.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2019, 221 (03) : 265.e1 - 265.e9
  • [37] Cost-effectiveness of molecular point-of-care testing for influenza viruses in elderly patients at ambulatory care setting
    You, Joyce H. S.
    Tam, Lok-pui
    Lee, Nelson L. S.
    PLOS ONE, 2017, 12 (07):
  • [38] Cost-effectiveness of ticagrelor in acute coronary syndromes
    Henriksson, Martin
    Janzon, Magnus
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2013, 13 (01) : 9 - 18
  • [39] Cost Effectiveness of a Point-of-Care Test for Adenoviral Conjunctivitis
    Udeh, Belinda L.
    Schneider, John E.
    Ohsfeldt, Robert L.
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2008, 336 (03): : 254 - 264
  • [40] COST-EFFECTIVENESS OF ICOSAPENT ETHYL IN PATIENTS WITH RECENT ACUTE CORONARY SYNDROME IN CATALONIA
    Mistry, C.
    Tilley, L.
    Comin-Colet, J.
    Vitale, G.
    Gaugris, S.
    Jakouloff, D.
    VALUE IN HEALTH, 2024, 27 (12) : S175 - S176